Preliminary total global full year 2025 revenue of approximately $616 millionPreliminary BRIUMVI U.S. fourth quarter and full year 2025 net ...
A group of international experts is proposing a first-of-its-kind framework to prevent multiple sclerosis (MS) from ...
Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...
41mon MSN
Novel immunotherapy demonstrates early potential to overcome resistance to immune checkpoint therapy
According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published in Nature Medicine, the novel monoclonal antibody linavonkibart has demonstrated the ...
News-Medical.Net on MSN
New CHEST guidelines offer evidence-based biologic selection for severe asthma
The American College of Chest Physicians (CHEST) recently released a new clinical guideline on biologic management in severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback